Selank
Selank
A synthetic peptide developed in Russia with anxiolytic (anti-anxiety) and nootropic properties. A modified fragment of tuftsin with enhanced stability and CNS effects.
Typical Cost
$35-90/vial (10mg)
Status
Research
Peptide Profile
Selank
Mechanism of Action
Modulates expression of neurotrophic factors, enhances GABAergic neurotransmission, modulates enkephalin degradation, and affects serotonin metabolism. Provides anxiolytic effects without sedation or addiction potential.
Common Dosages
intranasal
100-300mcg
Daily · 2-4 weeks
subcutaneous
200-500mcg
Daily · 2-4 weeks
Benefits
Reduced anxiety
Improved mood
Enhanced cognitive function
Better stress resilience
No sedation
Non-addictive
Side Effects
Mild headache
Nasal irritation
Slight drowsiness (rare)
Key Research
Selank in generalized anxiety disorder
Demonstrated anxiolytic effects comparable to benzodiazepines without sedation or withdrawal
Regulatory Status
Approved in Russia for anxiety and cognitive disorders. Research chemical in US. Not FDA-approved.
Contraindications
- ⚠Pregnancy/breastfeeding
GLP-1 users managing stress and anxiety during lifestyle changes may benefit from selank alongside SeraVia's wellness approach.
Learn More →Find peptide providers
Search 18,000+ clinics offering peptide therapy alongside GLP-1 medications.
Search Providers →Disclaimer: This information is for educational and research purposes only. Peptides described here may not be FDA-approved for human use. Always consult a qualified healthcare provider before using any peptide product. GLP1Search does not sell peptides.